Mangoceuticals, Inc. Common Stock (MGRX) — Financial Flexibility Index
Mangoceuticals, Inc. Common Stock (MGRX) has a Financial Flexibility Index of -0.16x as of June 2026. Free cash flow of $-260.51K (operating CF $-260.51K minus capex $0.00) represents 0% of total liabilities ($1.65 Million). Check MGRX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mangoceuticals, Inc. Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Mangoceuticals, Inc. Common Stock across 5 annual periods. For the full cash flow conversion analysis, see Mangoceuticals, Inc. Common Stock (MGRX) cash conversion ratio.
Annual Financial Flexibility Index for Mangoceuticals, Inc. Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for Mangoceuticals, Inc. Common Stock. Explore Mangoceuticals, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.57x | $-5.85 Million | $-5.85 Million | $890.57K | ▼ -92.5% |
| 2024 | -3.41x | $-4.86 Million | $-4.86 Million | $1.43 Million | ▲ +86.5% |
| 2023 | -25.34x | $-6.99 Million | $-7.00 Million | $276.04K | ▼ -656.7% |
| 2022 | -3.35x | $-1.30 Million | $-1.35 Million | $389.26K | ▼ -614.0% |
| 2021 | 0.65x | $25.58K | $-17.52K | $39.27K | — |